NeuroSense Therapeutics Ltd.
NRSN
$1.08
-$0.72-40.00%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 27.95% | -82.96% | -62.76% | -43.64% | |
| Total Receivables | -1.20% | -13.36% | 26.72% | -27.29% | |
| Inventory | -- | -- | -- | -- | |
| Prepaid Expenses | 24.29% | -- | -43.55% | -- | |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | |
| Other Current Assets | -12.50% | -7.89% | 11.11% | 60.87% | |
| Total Current Assets | 50.96% | -78.59% | -60.49% | -42.59% | |
|
|
|||||
| Total Current Assets | 50.96% | -78.59% | -60.49% | -42.59% | |
| Net Property, Plant & Equipment | -39.27% | -29.58% | -21.09% | -14.47% | |
| Long-term Investments | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | |
| Total Other Intangibles | -- | -- | -- | -- | |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | |
| Total Other Assets | 4.55% | -4.35% | -4.35% | -38.24% | |
| Total Assets | 43.64% | -76.60% | -58.73% | -41.65% | |
|
|
|||||
| Total Accounts Payable | -20.49% | 36.06% | 192.97% | 343.20% | |
| Total Accrued Expenses | -60.69% | -- | 65.89% | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | |
| Finance Division Debt Current | 5.80% | -- | 7.81% | -- | |
| Total Finance Division Other Current Liabilities | -- | 5.74% | -- | -- | |
| Total Other Current Liabilities | -- | 5.74% | -- | -- | |
| Total Current Liabilities | -42.41% | 16.74% | 100.41% | 246.36% | |
|
|
|||||
| Total Current Liabilities | -42.41% | 16.74% | 100.41% | 246.36% | |
| Long-Term Debt | -- | -- | -- | -- | |
| Short-term Debt | -- | -- | -- | -- | |
| Capital Leases | -- | -65.38% | -50.34% | -51.45% | |
| Finance Division Debt Non Current | -- | -- | -- | -- | |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | |
| Total Other Liabilities | -- | -- | -- | 572.25% | |
| Total Liabilities | -59.71% | -62.35% | 163.96% | 303.32% | |
|
|
|||||
| Common Stock & APIC | 61.08% | 8.20% | 11.46% | 13.49% | |
| Retained Earnings | -40.35% | -8.30% | -63.11% | -65.09% | |
| Treasury Stock & Other | -- | -- | -- | -- | |
| Total Common Equity | 246.84% | -10.23% | -130.10% | -102.50% | |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | |
| Preferred Stock Convertible | -- | -- | -- | -- | |
| Preferred Stock, Others | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | |
|
|
|||||
| Total Common Equity | 246.84% | -10.23% | -130.10% | -102.50% | |
| Total Preferred Equity | -- | -- | -- | -- | |
| Total Minority Interest | -- | -- | -- | -- | |
| Total Equity | 246.84% | -10.23% | -130.10% | -102.50% | |
|
|
|||||